Simon N. Haydar

Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders

Renza Roncarati, Carla Scali, Thomas A. Comery et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 99 citations

SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist

Simon N. Haydar, Chiara Ghiron, Laura Bettinetti et al. · Bioorganic & Medicinal Chemistry · 2009 · 41 citations · Full text

Biochemistry, Functional Selectivity, Medicine +8

Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonists Containing a Urea Moiety: Identification and Characterization of the Potent, Selective, and Orally Efficacious Agonist 1-[6-(4-Fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) Urea (SEN34625/WYE-103914)

Chiara Ghiron, Simon N. Haydar, Suzan Aschmies et al. · Journal of Medicinal Chemistry · 2010 · 30 citations · Full text

Brain Penetration, Pharmacotherapy, Medicinal Chemistry +18

Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789)

Riccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo et al. · Journal of Medicinal Chemistry · 2012 · 26 citations · Full text

5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT₆ Receptor Antagonists

Simon N. Haydar, Heedong Yun, Patrick M. Andrae et al. · Journal of Medicinal Chemistry · 2010 · 22 citations · Full text